DLHL
DARE icon

Donald L. Hagan LLC’s Dare Bioscience DARE Stock Holding History

Donald L. Hagan LLC’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-33
Closed -$11K – 142
2016
Q1 		$11K Sell
33
-92
-74% -$25.9K 0.01% 268
2015
Q4 		$42K Buy
125
+42
+51% +$17.4K 0.04% 71
2015
Q3 		$37K Buy
+83
New +$41.7K 0.03% 161

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Donald L. Hagan LLC's DARE Position: Q2 2016 in Review

Donald L. Hagan LLC sold out of Dare Bioscience (DARE) in Q2 2016, closing a stake of 33 shares — an estimated $11K sold.

Donald L. Hagan LLC first reported a position in DARE in Q3 2015 and held it in 3 quarters. The position peaked at $42K in Q4 2015. 34 funds tracked by Wall St. Rank hold DARE as of Q2 2016.

  • Donald L. Hagan LLC reported no remaining Dare Bioscience position as of Q2 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 33 Dare Bioscience shares in Q2 2016, an estimated $11K.
  • Donald L. Hagan LLC first reported a position in Dare Bioscience in Q3 2015 and held it in 3 quarters.
  • Donald L. Hagan LLC's Dare Bioscience position peaked at $42K in Q4 2015.
  • 34 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2016.

Based on Donald L. Hagan LLC's 13F filing for Q2 2016, filed 21 Jul 2016.